thalidomide has been researched along with Hypotension, Postural in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After decades of disuse because of its teratogenic effects, thalidomide has had a resurgence of use as a promising therapeutic agent for multiple myeloma." | 4.86 | Palliative oncology: thalidomide. ( Prommer, EE, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pandit, A | 1 |
| Gangurde, S | 1 |
| Gupta, SB | 1 |
| Prommer, EE | 1 |
1 review available for thalidomide and Hypotension, Postural
| Article | Year |
|---|---|
Palliative oncology: thalidomide.
Topics: Angiogenesis Inhibitors; Constipation; Cytokines; Drug Eruptions; Humans; Hydrolysis; Hypotension, O | 2010 |
1 other study available for thalidomide and Hypotension, Postural
| Article | Year |
|---|---|
Autonomic failure in primary amyloidosis.
Topics: Amyloidosis; Diagnosis, Differential; Humans; Hypotension, Orthostatic; Kidney Failure, Chronic; Mal | 2008 |